Single-dose psilocybin shows promise for treatment-resistant depression in NHS trial
A single 25-mg dose of psilocybin with psychological support was feasible to deliver within an NHS setting and produced large preliminary reductions in depressive symptoms among adults with treatment-resistant depression.…